Archives: Speakers

Lucy Xu is Director of Global Clinical Quality at Eisai Inc. Lucy is a passionate Quality Personnel with over 20 years of pharmaceutical drug discovery and development experience. Lucy holds a Ph.D. in Biology and worked in preclinical and translational medicine prior to venturing into the clinical quality area.  She is keen on process improvement, proactive CAPA, identification of gaps/root causes.  She uses her critical thinking skill on process-driven approach to quality. She has led various process improvement, training/education initiatives at Eisai.

A Longevity Actuary with 20 years of experience of managing longevity and other demographic risks, having worked in most areas of the longevity market including retail (underwritten and standard) and bulk annuities (insurance and pension scheme portfolios) and for insurance and reinsurance companies.

The former chair of the Actuarial Profession’s Mortality Research Steering Committee, member of ONS NPP Mortality Expert Panel and author of the prize winning paper “The Nature of Longevity Risk

I am a catastrophe risk and modelling professional with over 13 years of experience across global insurance markets, specialising in Specialty Insurance and commercial property portfolios. I currently serve as Head of Modelling at SCOR Business Solutions, leading the Single Risks CAT Modelling function across Property, Energy, Construction, Marine, Fine Art & Specie, and Political Violence.

I manage a diverse, international team of catastrophe modellers and external partners, overseeing CAT modelling, contribution, and accumulation to ensure accurate risk representation and strong underwriting decision‑making. I work closely with underwriters, pricing actuaries, and portfolio teams to translate complex model outputs into clear, actionable insights that support portfolio optimisation and capital efficiency.

I am particularly passionate about transformation streamlining CAT modelling processes, improving efficiency, and leveraging advanced analytics and machine learning. Previously, I held senior CAT modelling roles at AIG, including Regional Lead Modeller for EMEA, building deep end to end expertise in catastrophe risk management and team development.

Mary MacDonald is Director of Clinical Quality Assurance at Eisai, providing clinical quality leadership for outsourced development programs and enterprise‑level oversight of sponsor accountability and vendor governance under evolving GCP expectations. She brings more than 20 years of experience across clinical research and quality roles in large and mid‑size biopharma, including Takeda, Alexion (AstraZeneca Rare Disease), Radius Health, and bluebird bio. Mary works closely with clinical operations, procurement, and external partners to embed risk‑based quality practices and enable consistent execution across complex outsourcing models. She holds an MS in Clinical Research Organization and Management and is a Certified Quality Auditor and Registered QA Professional (GCP).

Sales director with 40 years of experience in business development, growth and GTM approach, Aldo Maria Camillo Caiani has a proven track record in matching Market and Customer needs with valuable business solutions addressing business processes optimization. He covered international roles as Managing Director, Senior Vice President, CEO, CBO (Chief Business Officer), CRO (Chief Revenue Officer) and Consultant in different Verticals working in SW (software) arena covering expertise on Manufacturing, Insurance, Banking, GDO, Food&Beverage, Financial Sector, Utilities and Energy.

Giuditta Carlotta Heinzl: Sensory and consumer researcher at Vinhood, she turns consumer data into actionable insight to support food innovation. She holds a PhD in Nutritional Sciences and has a strong scientific background in food science, she helps companies create products that truly connect with people’s needs, understanding consumer preferences and everyday choices that people make at the table.